Amalia Perna
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Amalia Perna has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Eloise Berson
Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA
2 shared publications - Alan Lee Chang
Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA
1 shared publication Anjali Sreenivas
Department of Pathology, Stanford University, Stanford, USA
1 shared publication- Brenna Cholerton
Department of Pathology Stanford University School of Medicine Stanford California USA
1 shared publication C. Dirk Keene
Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, 1959 NE Pacific St. Box 356100., Seattle, WA, 98195, USA
1 shared publication- Camilo Espinosa
Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA
1 shared publication
Latest Publications
- 27 September 2025
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 140, 108066
Epigenomic profile of GBA1 in Parkinson's disease
- 27 September 2025
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 140, 108066
Epigenomic profile of GBA1 in Parkinson's disease
- Open Access
- 16 August 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-11
Whole genome deconvolution unveils Alzheimer’s resilient epigenetic signature
Assay for Transposase Accessible Chromatin by sequencing (ATAC-seq) accurately depicts the chromatin regulatory state and altered mechanisms guiding gene expression in disease. However, bulk sequencing entangles information from different cell types and obscures cellular heterogeneity. To address this, we developed Cellformer, a deep learning method that deconvolutes bulk ATAC-seq into cell type-specific expression across the whole genome. Cellformer enables cost-effective cell type-specific open chromatin profiling in large cohorts. Applied to 191 bulk samples from 3 brain regions, Cellformer identifies cell type-specific gene regulatory mechanisms involved in resilience to Alzheimer’s disease, an uncommon group of cognitively healthy individuals that harbor a high pathological load of Alzheimer’s disease. Cell type-resolved chromatin profiling unveils cell type-specific pathways and nominates potential epigenetic mediators underlying resilience that may illuminate therapeutic opportunities to limit the cognitive impact of the disease. Cellformer is freely available to facilitate future investigations using high-throughput bulk ATAC-seq data.
- 16 August 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-11
Open AccessWhole genome deconvolution unveils Alzheimer’s resilient epigenetic signature
Assay for Transposase Accessible Chromatin by sequencing (ATAC-seq) accurately depicts the chromatin regulatory state and altered mechanisms guiding gene expression in disease. However, bulk sequencing entangles information from different cell types and obscures cellular heterogeneity. To address this, we developed Cellformer, a deep learning method that deconvolutes bulk ATAC-seq into cell type-specific expression across the whole genome. Cellformer enables cost-effective cell type-specific open chromatin profiling in large cohorts. Applied to 191 bulk samples from 3 brain regions, Cellformer identifies cell type-specific gene regulatory mechanisms involved in resilience to Alzheimer’s disease, an uncommon group of cognitively healthy individuals that harbor a high pathological load of Alzheimer’s disease. Cell type-resolved chromatin profiling unveils cell type-specific pathways and nominates potential epigenetic mediators underlying resilience that may illuminate therapeutic opportunities to limit the cognitive impact of the disease. Cellformer is freely available to facilitate future investigations using high-throughput bulk ATAC-seq data.